血管内皮细胞和血管生成
1Blue Ridge Institute for Medical Research, 221 Haywood Knolls Drive, Hendersonville, NC 28791, United States.
Pharmacological research
|October 12, 2025
概括
血管新生,新血管的形成,对于瘤生长和其他疾病至关重要. 抑制血管生成信号通路为癌症治疗提供了一个有前途的策略.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
背景情况:
- 血管内皮细胞分裂通常是有限的,但血管生成 (新的血管形成) 对于瘤生长超过1毫米是必不可少的,因为需要氧气和营养.
- 瘤血管生成涉及成熟的内皮细胞复制和形成新的毛细血管,通常是由血管内皮生长因子 (VEGFs) 的增加产生的.
研究的目的:
- 探索调节血管生成的分子机制,重点关注关键信号通路及其组成部分.
- 突出抑制癌症治疗中的血管源信号传递的治疗潜力.
主要方法:
- 对血管新生学文献的综述,包括VEGF家族,血红蛋白,血管蛋白,蛋白和其他生长因子及其受体的作用.
- 鉴定FDA批准的针对血管生成途径的药物.
主要成果:
- VEGF家族 (VEGF-A/B/C/D, PlGF) 和它们的受体 (VEGFR1/2/3,神经皮林) 是血管生成的核心.
- 赛马福林,血管蛋白,以弗林和各种生长因子 (PDGF,FGF,HGF,SCF) 也通过各自的受体发挥重要作用.
- 波纳替尼 (Ponatinib),雷戈拉费尼 (Regorafenib) 和万迪塔尼布 (Vandetanib) 是经批准的VEGFR,Tie2和埃弗林受体的抑制剂,在恶性瘤中显示出临床疗效.
结论:
- 异常血管生成与瘤进展和糖尿病视网膜病变和与年龄相关的黄斑变性等疾病有关.
- 抑制血管生成信号通路是各种癌症和其他血管生成依赖性疾病的可行和有吸引力的治疗策略.
关键词:
抗癌疗法是一种抗癌治疗.亚克西提尼布 (PubChem CID: 6450551) 的使用情况卡博赞提尼布 (PubChem CID: 25102847) 是一种药物.埃弗林受体的受体是什么眼睛治疗治疗眼睛治疗.伦瓦提尼布 (PubChem CID: 9823820) 是一种药物.尼丁达尼布 (PubChem CID: 135423438) 的使用情况普雷克辛受体是什么意思?波纳提尼布 (PubChem CID: 24826799) 的使用情况雷戈拉费尼布 (PubChem CID 11167602) 的使用情况半林受体的受体是什么索拉费尼布 (PubChem CID: 216239) 是一种药物.苏尼提尼布 (PubChem CID: 5329102) 是一种药物.提沃赞尼布 (PubChem CID: 9911830) 是一种药物,它可以丁丁尼布 (PubChem CID: 316967971) 是一种化学品.血管内皮生长因子受体 血管内皮生长因子受体相关概念视频
Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
Mechanism of Angiogenesis
6.7K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.7K
Overview of the Vascular System
3.4K
The vascular system comprises an extensive network of arteries, capillaries, and veins. The vascular system can be broadly divided into the blood and lymphatic systems. Typically, blood vessels can be categorized into three histological regions: tunica intima, tunica media, and tunica adventitia. The tunica intima consists of a single layer of endothelial cells attached to the basal lamina. Underlying the basal lamina is a connective tissue layer and an elastic lamina that gives stability and...
3.4K
Overview of Cell-Matrix Interactions
8.9K
The extracellular matrix or ECM holds cells together to form a tissue and allows the cells within the tissue to communicate. ECM comprises proteins such as fibronectin, collagen, laminin, etc. The most abundant protein in this space is collagen. Collagen fibers are interwoven with carbohydrate-containing protein molecules called proteoglycans. ECM allows cell migration and provides a structural scaffold at cell adhesion that anchors the cell when the extracellular matrix proteins interact with...
8.9K
Development of Blood Vessels
1.4K
The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
1.4K


